Effects of ingestion of a commercially available thermogenic dietary supplement on resting energy expenditure, mood state and cardiovascular measures

Table 2 Hemodynamic Measures

SBP, DBP, and HR Measurements Baseline to HR4
	SBP mean ± SD (mmHg)		DBP mean ± SD (mmHg)		HR mean ± SD (bpm)
	DBX	PLC	DBX	PLC	DBX	PLC
Baseline	100.58 ± 12.12	105.58 ± 8.08	60.50 ± 7.20	62.08 ± 5.42	58.25 ± 5.07	56.58 ± 7.10
HR1	113.0 ± 9.04	107.33 ± 6.04	65.33 ± 9.03	62.75 ± 5.36	55.17 ± 7.09	54.00 ± 9.94
HR2	110.67 ± 13.36	105.58 ± 8.96	60.25 ± 13.06	61.08 ± 8.28	55.33 ± 6.41	55.58 ± 10.94
HR3	114.17 ± 19.00	103.08 ± 6.75	67.25 ± 20.01	57.58 ± 6.67	55.92 ± 6.11	56.08 ± 7.66
HR4	108.92 ± 7.44	107.17 ± 9.48	61.75 ± 5.33	63.25 ± 8.75	56.83 ± 6.64	56.25 ± 7.64

SBP, DBP, and HR were recorded at baseline, HR1, HR2, HR3, and HR4.
Measurements for SBP and DBP are reported as mean ± SD and recorded in units of mmHg. Changes in SBP and DBP were not significant at any time point for either group. Heart rate measurements were reported as mean ± SD and recorded in beats per minute. Changes in HR were not significant at any time point for either group.

ISSN: 1550-2783